Skandinaviska Enskilda Banken (SEB)’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,800
| Closed | -$897K | – | 1118 |
|
|
2021
Q1 | $897K | Sell |
12,800
-13,600
| -52% | -$953K | 0.01% | 855 |
|
|
2020
Q4 | $1.58M | Hold |
26,400
| – | – | 0.01% | 713 |
|
|
2020
Q3 | $1.59M | Buy |
26,400
+15,500
| +142% | +$932K | 0.01% | 637 |
|
|
2020
Q2 | $572K | Buy |
+10,900
| New | +$572K | ﹤0.01% | 794 |
|
|
2019
Q3 | – | Sell |
-51,900
| Closed | -$2.26M | – | 932 |
|
|
2019
Q2 | $2.26M | Sell |
51,900
-23,300
| -31% | -$1.01M | 0.02% | 476 |
|
|
2019
Q1 | $2.86M | Buy |
75,200
+15,600
| +26% | +$594K | 0.03% | 386 |
|
|
2018
Q4 | $2.56M | Sell |
59,600
-11,300
| -16% | -$486K | 0.02% | 404 |
|
|
2018
Q3 | $3.49M | Sell |
70,900
-4,300
| -6% | -$211K | 0.03% | 363 |
|
|
2018
Q2 | $2.41M | Sell |
75,200
-8,100
| -10% | -$260K | 0.02% | 391 |
|
|
2018
Q1 | $2.6M | Buy |
83,300
+72,500
| +671% | +$2.26M | 0.03% | 328 |
|
|
2017
Q4 | $493K | Sell |
10,800
-64,800
| -86% | -$2.96M | ﹤0.01% | 645 |
|
|
2017
Q3 | $2.84M | Hold |
75,600
| – | – | 0.03% | 394 |
|
|
2017
Q2 | $3.61M | Sell |
75,600
-4,400
| -6% | -$210K | 0.03% | 355 |
|
|
2017
Q1 | $3.65M | Sell |
80,000
-43,400
| -35% | -$1.98M | 0.04% | 335 |
|
|
2016
Q4 | $3.99M | Sell |
123,400
-800
| -0.6% | -$25.8K | 0.05% | 263 |
|
|
2016
Q3 | $4.25M | Buy |
+124,200
| New | +$4.25M | 0.05% | 286 |
|